Canada's Provincial and Territorial Routine (and Catch-up) Vaccination Programs for Infants and Children

This table summarizes the current routine vaccination schedule for infants and children in all provinces and territories across Canada.  Provincial and territorial schedules change regularly. This schedule is updated regularly in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC); and schedules for each province or territory can be found on their website. Individuals are also encouraged to talk to their healthcare providers about recommended vaccines.

The Canadian Immunization Guide is an online resource for health care professionals and includes more information about vaccines, vaccine safety and the recommended immunization schedules. Additional information on vaccine safety, epidemiology, and guidance on immunization and vaccines is available on Immunization and vaccines. (last update: December 2017)

2017

Alternative Formats

Vaccination Schedules
Vaccines Provinces & Territories
Abbreviations Descriptions BC AB SK MB ON QC NB NS PE NL YT NT NU
DTaP-IPV-Hib Diphtheria, Tetanus, acellular Pertussis, Inactivated Polio Virus, Haemophilus Influenzae type B vaccine Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
6 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months		 Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
18 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months
DTaP-HB-IPV-Hib Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Virus, Haemophilus Influenzae type B vaccine Age:
2, 4, 6 months		 N/A N/A N/A N/A Age:
2, 4, 18 months		 N/A N/A Age:
2, 4, 6 months		 N/A Age:
2, 4, 6 months		 N/A N/A
DTaP-IPV or Tdap-IPVFootnote a Diphtheria, Tetanus, acellular Pertussis, Inactivated Polio Virus vaccine, or Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid), Inactivated Polio Virus vaccine Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4 years		 Age:
4-6 years		 Age:
4-5 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years		 Age:
4-6 years
Tdap Tetanus, diphtheria (reduced toxoid), acellular pertussis (reduced toxoid) vaccine Grade: 9 Grade: 9 Grade: 8 Age:
14-16 years		 Age:
14-16 years		 3rd year of high school Grade: 7 Grade: 7 Grade: 9 Grade: 9 Grade: 9 Grade: 7 Grade: 6
HB Hepatitis B vaccine HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 (3-dose)
Grade: 5		 (2-dose)
Grade: 6		 (2-dose), Grade: 6 (2-dose)
Grade: 7		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy
Catch-up (2-dose) 2013/14 to 2022/23 Grade: 4		 Age:
At birth, 2, 6 months		 (2-dose)
Grade: 7		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 (2-dose)
Grade: 6		 HB is provided
in a 3-dose combination vaccine
(DTaP-HB-
IPV-Hib) in infancy		 Age:
At birth, 1, 6 months		 Age:
At birth, 1, 9 months
MMR Measles, Mumps, Rubella vaccine Age:
12 months		 N/A N/A N/A Age:
12 months		 Age:
12 months		 N/A N/A N/A N/A Age:
12 months		 N/A Age:
12, 18 months
Var Varicella vaccine Age:
12 months		 N/A Catch-up (2nd dose) 2015 to 2021 Grade: 6 N/A Age:
15 months		 Age: 4-6 yrs Catch-up (2nd dose) 2016/17 to 2022/23 Grade: 9 N/A N/A N/A Age:
12 months		 N/A Age:
15 months
MMRV Measles, Mumps, Rubella, Varicella vaccine 2nd dose
Age:
4-6 years		 Age:
12 months, 4-6 years		 Age:
12, 18 months		 Age:
12 months, 4-6 years		 2nd dose
Age:
4-6 years		 Age:
18 months		 Age:
12, 18 months		 Age:
12, 18 months-6 yrs		 Age:
12, 18 months		 Age:
12, 18 months		 2nd dose
Age:
4-6 years		 Age:
12, 36 months		 N/A
Men-C-C Meningococcal conjugate (Strain C) vaccine Age:
2, 12 months		 Age:
4, 12 months		 Age:
12 months		 Age:
12 monthsFootnote 4		 Age:
12 months		 Age:
12 months,
3rd year of high school		 Age:
12 months		 Age:
12 months		 Age:
12 months		 Age:
12 months		 Age:
2, 12 months
 Age:
2, 12 months		 Age:
12 months
Men-C-ACYW-135 Meningococcal conjugate (Strains A, C, Y, W135) vaccine Grade: 9 Grade: 9 Grade: 6 N/A Grade: 7 N/A Grade: 9 Grade: 7 Grade: 9 Grade: 4 Grade 9 Grade: 12
Footnote b		 Grade 9
Pneu-C-13 Pneumococcal conjugate (13-valent) vaccine Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 12 months		 Age:
2, 4, 6 if high risk, 12 months		 Age: 2, 4, 6 if high risk12 mos Age:
2, 4, 12 months		 Age:
2, 4, 6, 18 months		 Age:
2, 4, 6, 18 months
Inf Influenza vaccine Age:
6-59 months		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months		 Age:
6-23 months		 Age:
6 months-18 years		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months		 Age:
6+ months
Rota Rotavirus vaccine Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 Starting June 2017 Age: 2,4 months N/A Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 Age:
2, 4 months		 N/A
HPV Human Papillomavirus vaccine (2-dose)
Grade: 6Footnote 1
 (3-dose)
Grade: 5Footnote 1

Catch-up
(3-dose) 2014 to 2018 Grade: 9
Footnote 3		 (2-dose) Grade: 6 Footnote 1 (2-dose) Grade: 6 Footnote 1

Catch-up
(2-dose)
Grade: 8,9Footnote 3		 (2-dose) Grade: 7 Footnote 1

Catch-up (2 or 3 -dose) Grade 8Footnote 1, Grades 9 to 12Footnote 2		 (2-dose)
Grade: 4Footnote 1

 (2-dose)
Grade 7Footnote 1		 (2-dose) Grade: 7Footnote 1 (2-dose)
Grade: 6Footnote 1		 (2-dose) Grade: 6Footnote 1 (2-dose) Grade: 6Footnote 1 (9-14 years: 2-dose 15 years +: 3-dose)
Grade: 4-6Footnote 1		 (2-dose)
Grade: 6Footnote 1
Footnote a

NACI recommends either DTaP-IPV or Tdap-IPV vaccines may be used for the 4-6 year old booster in children.

Return to footnote a referrer

Footnote b

If attending post-secondary school out-of territory.

Return to footnote b referrer

Footnote 1

Females and males

Return to first footnote 1 referrer

Footnote 2

Females only

Return to first footnote 2 referrer

Footnote 3

Males only

Return to first footnote 3 referrer

Footnote 4

Starting as early as September 2019, Manitoba's Meningococcal School-Based Immunization Program will be offered at a later grade: no child will miss the opportunity to be vaccinated.

Return to footnote 4 referrer
Report a problem or mistake on this page

Privacy statement

The information you provide through this survey is collected under the authority of the Department of Employment and Social Development Act (DESDA) for the purpose of measuring the performance of Canada.ca and continually improving the website. Your participation is voluntary.

Please do not include sensitive personal information in the message box, such as your name, address, Social Insurance Number, personal finances, medical or work history or any other information by which you or anyone else can be identified by your comments or views.

Any personal information collected will be administered in accordance with the Department of Employment and Social Development Act, the Privacy Act and other applicable privacy laws governing the protection of personal information under the control of the Department of Employment and Social Development. Survey responses will not be attributed to individuals.

If you wish to obtain information related to this survey, you may submit a request to the Department of Employment and Social Development pursuant to the Access to Information Act. Instructions for making a request are provided in the publication InfoSource, copies of which are located in local Service Canada Centres.

You have the right to file a complaint with the Privacy Commissioner of Canada regarding the institution’s handling of your personal information at: How to file a complaint.

When making a request, please refer to the name of this survey: Report a Problem or Mistake on This Page.

Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: